SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001720725-19-000002
Filing Date
2019-02-27
Accepted
2019-02-27 14:34:02
Documents
1
Effectiveness Date
2019-02-27
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10120
  Complete submission text file 0001720725-19-000002.txt   11196
Mailing Address 700 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540
Business Address 700 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-333703 | Film No.: 19637078